Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

CCL21-loaded 3D hydrogels for T cell expansion and differentiation

  • Pérez del Río, Eduardo
  • Santos, Fabiao
  • Rodríguez Rodríguez, Xavier
  • Martínez Miguel, Marc
  • Roca Pinilla, Ramon
  • Arís, Anna
  • García Fruitós, Elena
  • Veciana, Jaume
  • Spatz, Joachim P.
  • Ratera, Immaculada
  • Guasch, Judit
Recent achievements in the field of immunotherapy, such as the development of engineered T cells used in adoptive cell therapy, are introducing more efficient strategies to combat cancer. Nevertheless, there are still many limitations. For example, these T cells are challenging to manufacture, manipulate, and control. Specifically, there are limitations in producing the large amounts of therapeutic T cells needed for these therapies in a short period of time and in an economically viable manner. In this study, three-dimensional (3D) poly(ethylene) glycol (PEG) hydrogels covalently combined with low molecular weight heparin are engineered to resemble the lymph nodes, where T cells reproduce. In these hydrogels, PEG provides the needed structural and mechanical properties, whereas heparin is used as an anchor for the cytokine CCL21, which is present in the lymph nodes, and can affect cell migration and proliferation. The 3D structure of the hydrogel in combination with its loading capacity result in an increased primary human CD4+ T cell proliferation compared to the state-of-the-art expansion systems consisting of artificial antigen presenting cells. Thus, we present a new tool for adoptive cell therapy to help achieving the large numbers of cells required for therapy of selected phenotypes targeted against cancer cells, by mimicking the lymph nodes., We acknowledge D. P. Rosenblatt for proofreading this manuscript and the “Servei de Microscòpia” from UAB for assistance in the confocal microscopy. The authors are grateful for the financial support received from the Spanish Ministry of Economy and Competitiveness MINECO (MAT2016-80826-R, PID2019-105622RBI00, the “Ramón y Cajal” program (RYC-2017-22614), and a DOC-INIA fellowship), the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN) through the projects “Alycia” (Nr. BBN18PI01) and “Gels4ACT” (Nr. BBN20PIV02), Generalitat de Catalunya (SGR-918, SGR-229, CERCA Programme, and AGAUR for a pre‐doctoral fellowship (FI-AGAUR)), Fundació Marató de TV3 (Nr. 201812), and the European Social Fund. This research was also supported by the People Programme (Marie Curie Actions) of the 7th Framework Programme of the European Union (FP7/2007–2013) through the grant agreement Nr. 600388 of REA with the Agency for Business Competitiveness ACCIÓ through a Tecniospring fellowship (TECSPR15-1-0015) and the European Union's Horizon 2020 research and innovation programme H2020-MSCA-COFUND-2016 (DOC-FAM, grant agreement Nr. 754397). The work was funded as well by the Max Planck Society through the Max Planck Partner Group “Dynamic Biomimetics for Cancer Immunotherapy” in collaboration with the Max Planck for Medical Research (Heidelberg, Germany). ICMAB-CSIC acknowledges support from the MINECO through the Severo Ochoa Programme for Centres of Excellence in R&D (SEV-2015-0496; FIP fellowship). This work has been developed inside the biochemistry and biomedicine PhD program of UAB., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Structural Study of the Hydration of Lipid Membranes Upon Interaction With Mesoporous Supports Prepared by Standard Methods and/or X‐Ray Irradiation

  • Marmiroli, Benedetta
  • Sartori, Barbara
  • Kyvik Ruiz, Adriana
  • Ratera, Immaculada
  • Amenitsch, Heinz
Mesoporous materials feature ordered tailored structures with uniform pore sizes and highly accessible surface areas, making them an ideal host for functional organic molecules or nanoparticles for analytical and sensing applications. Moreover, as their porosity could be employed to deliver fluids, they could be suitable materials for nanofluidic devices. As a first step in this direction, we present a study of the hydration of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) model lipid membranes on solid mesoporous support. POPC was selected as it changes the structure upon hydration at room temperature. Mesoporous films were prepared using two different templating agents, Pluronic P123 (PEO–PPO–PEO triblock copolymer where PEO is polyethylene oxide and PPO is polypropylene oxide) and Brij 58 (C16H33(EO)20OH where EO is ethylene oxide), both following the conventional route and by X-ray irradiation via deep X-ray lithography technique and subsequent development. The same samples were additionally functionalized with a self-assembly monolayer (SAM) of (3-aminopropyl)triethoxysilane. For every film, the contact angle was measured. A time resolved structural study was conducted using in situ grazing incidence small-angle X-ray scattering while increasing the external humidity (RH), from 15 to 75% in a specially designed chamber. The measurements evidenced that the lipid membrane hydration on mesoporous films occurs at a lower humidity value with respect to POPC deposited on silicon substrates, demonstrating the possibility of using porosity to convey water from below. A different level of hydration was reached by using the mesoporous thin film prepared with conventional methods or the irradiated ones, or by functionalizing the film using the SAM strategy, meaning that the hydration can be partially selectively tuned. Therefore, mesoporous films can be employed as “interactive” sample holders with specimens deposited on them. Moreover, thanks to the possibility of patterning the films using deep X-ray lithography, devices for biological studies of increasing complexity by selectively functionalizing the mesopores with biofunctional SAMs could be designed and fabricated., This research was partly supported by the European Commission under grant agreement 654360 NFFA-EUROPE. This work includes part of the scientific activities of the internal CERIC-ERIC project renewals. The authors are thankful to C. Morello and L. Sancin for their technical support. IR is grateful to the support of the Spanish Ministry of Economy and Competitiveness (MINECO) (PID2019-105622RBI00) through the Severo Ochoa Programme for Centres of Excellence in R&D (CEX 2019-000917-S), Instituto de Salud Carlos III through the Networking Research Center on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Generalitat de Catalunya (SGR-918), and Fundacio Marato de TV3 (No. 201812)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Polylactide, Processed by a Foaming Method Using Compressed Freon R134a, for Tissue Engineering

  • Aguado, María
  • Saldaña, Laura
  • Pérez del Río, Eduardo
  • Guasch, Judit
  • Parera, Marc
  • Córdoba, Alba
  • Seras Franzoso, Joaquín
  • Cano Garrido, Olivia
  • Vázquez, Esther
  • Villaverde, Antonio
  • Veciana, Jaume
  • Ratera, Immaculada
  • Vilaboa, Nuria
  • Ventosa, Nora
Fabricating polymeric scaffolds using cost-effective manufacturing processes is still challenging. Gas foaming techniques using supercritical carbon dioxide (scCO2) have attracted attention for producing synthetic polymer matrices; however, the high-pressure requirements are often a technological barrier for its widespread use. Compressed 1,1,1,2-tetrafluoroethane, known as Freon R134a, offers advantages over CO2 in manufacturing processes in terms of lower pressure and temperature conditions and the use of low-cost equipment. Here, we report for the first time the use of Freon R134a for generating porous polymer matrices, specifically polylactide (PLA). PLA scaffolds processed with Freon R134a exhibited larger pore sizes, and total porosity, and appropriate mechanical properties compared with those achieved by scCO2 processing. PLGA scaffolds processed with Freon R134a were highly porous and showed a relatively fragile structure. Human mesenchymal stem cells (MSCs) attached to PLA scaffolds processed with Freon R134a, and their metabolic activity increased during culturing. In addition, MSCs displayed spread morphology on the PLA scaffolds processed with Freon R134a, with a well-organized actin cytoskeleton and a dense matrix of fibronectin fibrils. Functionalization of Freon R134a-processed PLA scaffolds with protein nanoparticles, used as bioactive factors, enhanced the scaffolds' cytocompatibility. These findings indicate that gas foaming using compressed Freon R134a could represent a cost-effective and environmentally friendly fabrication technology to produce polymeric scaffolds for tissue engineering approaches., This work was supported by the Spanish Ministry of Economy and Competitiveness (MOTHER MAT2016-80826-R and Mol4Bio PID2019-105622RBI00); Spanish Ministry of Science, Innovation and Universities (RTI2018-095159-B-100); Instituto de Salud Carlos III (ISCIII)- European Regional Development Fund (ERDF); MINECO-AES (PI15/00752, PI15/01118 and PI18/00643); the Networking Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN); CSIC through grant 2019AEP133; Comunidad Autónoma de Madrid (grant S2013/MIT-2862); Generalitat de Catalunya (grants 2017-SGR-918, 2017-SGR-229 and CERCA Programme); the Fundació Marató de TV3 (Nr. 201812); the COST Action CA15126 Between Atom and Cell; and the European Social Fund and EU to J.V., A.V. and I.R. (H2020-INFRAIA-2014-2015; NFFA-654360)., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Strategies for surface coatings of implantable cardiac medical devices

  • Coronel Meneses, David
  • Sánchez Trasviña, Calef
  • Ratera, Immaculada
  • Mayolo Deloisa, Karla
Cardiac medical devices (CMDs) are required when the patient's cardiac capacity or activity is compromised. To guarantee its correct functionality, the building materials in the development of CMDs must focus on several fundamental properties such as strength, stiffness, rigidity, corrosion resistance, etc. The challenge is more significant because CMDs are generally built with at least one metallic and one polymeric part. However, not only the properties of the materials need to be taken into consideration. The biocompatibility of the materials represents one of the major causes of the success of CMDs in the short and long term. Otherwise, the material will lead to several problems of hemocompatibility (e.g., protein adsorption, platelet aggregation, thrombus formation, bacterial infection, and finally, the rejection of the CMDs). To enhance the hemocompatibility of selected materials, surface modification represents a suitable solution. The surface modification involves the attachment of chemical compounds or bioactive compounds to the surface of the material. These coatings interact with the blood and avoid hemocompatibility and infection issues. This work reviews two main topics: 1) the materials employed in developing CMDs and their key characteristics, and 2) the surface modifications reported in the literature, clinical trials, and those that have reached the market. With the aim of providing to the research community, considerations regarding the choice of materials for CMDs, together with the advantages and disadvantages of the surface modifications and the limitations of the studies performed., This project has received funding from the European Union’s Horizon 2020 research and innovation program under the Marie Skłodowska-Curie grant agreement No. 801342 (Tecniospring INDUSTRY) and from the Government of Catalonia’s Agency for Business Competitiveness (ACCIÓ; TECSPR19-1-0065). IR has received funding from European Union’s Horizon 2020 research and innovation program in HORIZON-RIA action (Nabiheal; Grant agreement 101092269); MICINN (Grant agreement PID 2019-105622RBI00); Instituto de Salud Carlos III (ISCIII) through the Networking Research Center on Bioengineering, Biomaterialsand Nanomedicine, CIBER-BBN; the Fundació Marató de TV3 (Nr.201812) and Generalitat de Catalunya (2021 SGR 00438). All figures were designed with BioRender.com., With funding from the Spanish government through the ‘Severo Ochoa Centre of Excellence’ accreditation (CEX2019-000917-S)., Peer reviewed